Pembrolizumab

Surgical Safety of Radical Cystectomy and Pelvic Lymph Node Dissection Following Neoadjuvant Pembrolizumab in Patients with Bladder Cancer: Prospective Assessment of Perioperative Outcomes from the PURE-01 Trial

Alberto Briganti, Giorgio Gandaglia, Simone Scuderi, Andrea Gallina, Renzo Colombo, Nicola Fossati, Francesco Barletta, Antony Pellegrino, Luigi Nocera, Francesco Montorsi, Andrea Necchi

Citations: 69 • 2020

Safety and effectiveness of pembrolizumab combined with paclitaxel and cisplatin as neoadjuvant therapy followed by surgery for locally advanced resectable (stage III) esophageal squamous cell carcinoma: a study protocol for a prospective, single-arm, single-center, open-label, phase-II trial (Keystone-001)

Xiaobin Shang, Gang Zhao, Fei Liang, Chen Zhang, Wei‐Hong Zhang, Liang Liu, Runmei Li, Xiaofeng Duan, Zhao Ma, Jie Yue, Chuangui Chen, Bin Meng, Xiubao Ren, Hongjing Jiang

Citations: 62 • 2022

French AFU Cancer Committee Guidelines - Update 2022-2024: management of kidney cancer

Pierre Bigot, Philippe Barthélémy, R. Boissier, Z. Khene, C. Pettenati, Jean‐Christophe Bernhard, J.M. Corréas, N. Doumerc, P. Gimel, Alexandre Ingels, F-X. Nouhaud, Idir Ouzaïd, Laurence Albigès, Morgan Rouprêt

Citations: 51 • 2022

1O Dynamic circulating tumour DNA (ctDNA) response to neoadjuvant (NA) atezolizumab (atezo) and surgery (surg) and association with outcomes in patients (pts) with NSCLC

Mark G. Kris, Jessica M. Grindheim, Jamie E. Chaft, J.M. Lee, Bruce E. Johnson, Valerie W. Rusch, Paul A. Bunn, Harvey I. Pass, E. Schum, Jennifer W. Carlisle, M. Weyant, A. Nicholas, Ann Johnson, D. Shames, Ignacio I. Wistuba, David P. Carbone, Katja Schulze, David J. Kwiatkowski

Citations: 35 • 2021

Recommandations françaises du Comité de cancérologie de l’AFU – actualisation 2020–2022 : prise en charge du cancer du rein

Karim Bensalah, Pierre Bigot, Laurence Albigès, Jean‐Christophe Bernhard, Thomas Bodin, R. Boissier, Jean-Michel Corréas, P. Gimel, Jean François Hetet, Jean‐Alexandre Long, F. Nouhaud, Idir Ouzaïd, Arnaud Méjean

Citations: 24 • 2020

Perioperative Complications and Oncologic Outcomes of Nephrectomy Following Immune Checkpoint Inhibitor Therapy: A Multicenter Collaborative Study

Wesley Yip, Alireza Ghoreifi, Thomas Gerald, Randall Lee, Jeffrey Howard, Aeen Asghar, Abhinav Khanna, Jie Cai, Manju Aron, Inderbir S. Gill, R. Houston Thompson, Robert G. Uzzo, Vitaly Margulis, Nirmish Singla, Hooman Djaladat

Citations: 23 • 2023

Complete Response of Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC)-Associated Renal Cell Carcinoma to Pembrolizumab Immunotherapy: A Case Report

Tao Wang, Yan Huang, Xing Huang, Zheng Lv, Shuo Tian, Xin Ma, Xu Zhang

Citations: 21 • 2021

The Adrenal Gland as a Sanctuary Site of Metastases After Pembrolizumab Treatment: A Case Series

Michelle Nguyen, Manisha H. Shah, David A. Liebner, Floor Backes, John E. Phay, Lawrence A. Shirley

Citations: 21 • 2018

Elective Cytoreductive Nephrectomy After Checkpoint Inhibitor Immunotherapy in Patients With Initially Unresectable Metastatic Clear Cell Renal Cell Carcinoma

Melissa A. Reimers, R. Sherburne Figenshau, Eric H. Kim, Julie Tucker, Nicole Kasten, Adeel Khan, Jan M. Hanneken, Zachary L. Smith, James J. Hsieh

Citations: 19 • 2020

Salvage pulmonary resection in stages IIIb–IV lung cancer after treatment with immune checkpoint inhibitors case series and literature review

Alex Smith, Anuj Wali, Ana Fernández Montés, Maher Hadaki, Karen Harrison‐Phipps, Eleni Karapanagiotou, Andrea Billè

Citations: 17 • 2021

Neoadjuvant Chemotherapy or Immunotherapy for Clinical T2N0 Muscle-invasive Bladder Cancer: Time to Change the Paradigm?

Filippo Pederzoli, Marco Bandini, Laura Marandino, Daniele Raggi, Patrizia Giannatempo, Andrea Salonia, Andrea Gallina, Alberto Briganti, Francesco Montorsi, Andrea Necchi

Citations: 13 • 2020

LBA3 Safety and efficacy of pembrolizumab combined with paclitaxel and cisplatin as a neoadjuvant treatment for locally advanced resectable (stage III) esophageal squamous cell carcinoma (Keystone-001): Interim analysis of a prospective, single-arm, single-center, phase II trial

Xianwen Shang, Chao Zhang, Gang Zhao, W. Zhang, L. Liu, Xingyu Duan, J. Yue, Zhao Ma, C. Chen, Bin Meng, Xiubao Ren, Hongjing Jiang

Citations: 13 • 2021

Primary Malignant Melanoma of the Bladder Treated by Robotic Partial Cystectomy and Immunotherapy

Fahad Chaus, Miguel Craig, Erika Bracamonte, Srinath Sundararajan, Benjamin R. Lee

Citations: 7 • 2019

Advanced Renal Cell Carcinoma With Inferior Vena Cava Thrombus Treated With a Combination of Preoperative Lenvatinib and Pembrolizumab

Chika Nagahisa, Kazuhiko Yoshida, Hanae Kondo, Takayuki Nakayama, SHINSUKE MIZOGUCHI, Ryo Minoda, Hironori Fukuda, Yuki Kobari, Junpei Iizuka, Yoji Nagashima, Hideki Ishida, Toshio Takagi

Citations: 5 • 2024

A case of metastatic renal cell carcinoma successfully treated with deferred cytoreductive nephrectomy following lenvatinib plus pembrolizumab combination therapy

Hiroaki Sato, Tomokazu Sazuka, Ayumi Fujimoto, Sakurako Kagitani, Takayuki Arai, Yusuke Goto, Yusuke Imamura, Shinichi Sakamoto, Jun‐ichiro Ikeda, Tomohiko Ichikawa

Citations: 3 • 2023

Metastatic Urothelial Carcinoma With Sarcomatoid Subtype After Robot-Assisted Radical Cystectomy Successfully Treated With Pembrolizumab

K Murase, Keita Nakane, Makoto Kawase, Koji Iinuma, Takuya Koie

Citations: 3 • 2024

Efficacy of Combined Pembrolizumab and Pelvic Radiotherapy for Bladder Cancer With Rectal Metastases

Chika Nagahisa, Junpei Iizuka, Yuki Kobari, Ryo Minoda, Hironori Fukuda, Kazuhiko Yoshida, Hisashi Okuda, Hideki Ishida, Yoji Nagashima, Toshio Takagi

Citations: 2 • 2023

A case report of robot-assisted radical nephrectomy and inferior vena cava thrombectomy in a patient with renal cell carcinoma after pembrolizumab and axitinib combination therapy

Ryo Shiode, Terutaka Noda, Shota Nobumori, Naoya Sugihara, Maki Yamakawa, Kaori Saiki, Takatora Sawada, Reina Kono, Toshio Kakuda, Kenichi Nishimura, Tetsuya Fukumoto, Noriyoshi Miura, Tadahiko Kikugawa, Takashi Saika

Citations: 1 • 2024

A case of remarkable response to combined radiation therapy, enfortumab vedotin, and pembrolizumab in metastatic urothelial carcinoma

Fumihiko Urabe, Keigo Sakanaka, Yuma Goto, Katsuki Muramoto, Soshi Kadena, Hajime Onuma, Kosuke Iwatani, Yu Imai, Kojiro Tashiro, Takahiro Kimura, Tatsuya Shimomura

Citations: 1 • 2025